SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AviadoBio Presents Preclinical Data on vMiX Platform and AVB-406

AviadoBio presented preclinical data on its vMiX platform for AVB-406 in Alzheimer’s disease and AVB-SNCA in Parkinson’s disease at ESGCT 2026. A single intravenous dose of AVB-406 maintained MAPT mRNA knockdown and reduced total tau protein by 8; the source does not specify a unit or comparison.

SquawkNews Desk

Related stories

Amazon Shares Fall on Weak Fourth-Quarter Sales Estimates and Cash Burn Amazon shares fell after weak sales estimates for the fourth quarter and cash burn were reported. M impact | EQUITY | Oct 29, 2026, 09:22 PM UTC Weyerhaeuser Reports Higher Q3 Adjusted Earnings and Revenue Weyerhaeuser reported higher adjusted earnings and revenue for Q3. M impact | EQUITY | Oct 29, 2026, 09:15 PM UTC Intel CEO Says 18A-P Remains on Track for Year-End Launch The CEO said Intel 18A-P remains on track for launch by year-end across Intel's internal product portfolio. M impact | EQUITY | Oct 29, 2026, 09:14 PM UTC Republic Services Q3 Profit Rises to $592 Million Republic Services reported third-quarter earnings of $592 million, or $1.93 per share, compared with $550 million, or $1.76 per share, a year earlier. M impact | EQUITY | Oct 29, 2026, 09:13 PM UTC Intel CEO Says Panther Lake Ramp Succeeded, Wildcat Lake Demand Exceeds Supply Intel’s CEO said Panther Lake has successfully ramped on Intel 18A and demand for Wildcat Lake is outstripping supply. M impact | EQUITY | Oct 29, 2026, 09:12 PM UTC Southern Missouri Bancorp Appoints Matthew T. Funke CFO Southern Missouri Bancorp appointed Matthew T. Funke as principal financial officer, according to an SEC filing. M impact | EQUITY | Oct 29, 2026, 09:11 PM UTC